We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+9.56%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.95B
AUM Growth
+$323M
Cap. Flow
+$326M
Cap. Flow %
8.24%
Top 10 Hldgs %
35.62%
Holding
121
New
38
Increased
29
Reduced
19
Closed
34

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$100M
2
MCK icon
McKesson
MCK
+$82.1M
3
SYK icon
Stryker
SYK
+$68M
4
PFE icon
Pfizer
PFE
+$67.6M
5
GILD icon
Gilead Sciences
GILD
+$63.5M

Sector Composition

Rank Sector Weight
1 Healthcare 47.61%
2 Technology 10.42%
3 Communication Services 8.14%
4 Industrials 7%
5 Financials 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLVS
1
DELISTED
Clovis Oncology, Inc.
CLVS
$238M 6.04%
2,713,661
+446,905
+20% +$38.3M
HCA icon
2
HCA Healthcare
HCA
$82.8B
$186M 4.7%
2,045,283
+1,089,523
+114% +$87.3M
AER icon
3
AerCap
AER
$23.4B
$144M 3.64%
3,141,755
+1,074,182
+52% +$50.9M
BRCM
4
DELISTED
BROADCOM CORP CL-A
BRCM
$141M 3.57%
2,738,423
+485,728
+22% +$23.6M
BMY icon
5
Bristol-Myers Squibb
BMY
$124B
$140M 3.54%
2,103,968
+1,308,622
+165% +$86.2M
WBA
6
DELISTED
Walgreens Boots Alliance
WBA
$133M 3.36%
1,572,021
+202,542
+15% +$17.5M
EW icon
7
Edwards Lifesciences
EW
$48.9B
$127M 3.22%
5,362,938
+1,739,712
+48% +$39.3M
LBTYK icon
8
Liberty Global Class C
LBTYK
$3.36B
$107M 2.71%
2,615,328
+1,321,699
+102% +$54.8M
AET
9
DELISTED
Aetna Inc
AET
$99.4M 2.52%
+779,930
New +$89M
MIC
10
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$91.5M 2.32%
1,107,486
-174,107
-14% -$14.7M
VMC icon
11
Vulcan Materials
VMC
$36.4B
$87.7M 2.22%
1,044,754
-568,279
-35% -$49.6M
META icon
12
Meta Platforms (Facebook)
META
$1.63T
$86.8M 2.2%
1,012,632
+275,773
+37% +$22.5M
HUM icon
13
Humana
HUM
$47.8B
$84.7M 2.15%
443,063
+44,371
+11% +$8.24M
ELV icon
14
Elevance Health
ELV
$82.9B
$84.3M 2.13%
+513,715
New +$82.1M
JAZZ icon
15
Jazz Pharmaceuticals
JAZZ
$15.3B
$81.9M 2.07%
465,414
-59,589
-11% -$10.7M
AAPL icon
16
Apple
AAPL
$4.81T
$80.7M 2.04%
2,573,348
+850,700
+49% +$27.2M
EXP icon
17
Eagle Materials
EXP
$6.23B
$76.8M 1.94%
1,005,739
+544,524
+118% +$45M
HOLX
18
DELISTED
Hologic
HOLX
$73.2M 1.85%
1,923,762
-1,143,254
-37% -$40M
VMW
19
DELISTED
VMware, Inc
VMW
$72.2M 1.83%
+841,721
New +$73.4M
UHS icon
20
Universal Health Services
UHS
$9.08B
$72.1M 1.83%
+507,441
New +$63.6M
TEVA icon
21
Teva Pharmaceuticals
TEVA
$36.5B
$71.5M 1.81%
1,208,964
+410,267
+51% +$25.3M
PANW icon
22
Palo Alto Networks
PANW
$279B
$69.2M 1.75%
2,376,000
-630,492
-21% -$16.8M
THC icon
23
Tenet Healthcare
THC
$16.7B
$67M 1.7%
1,156,814
-286,614
-20% -$14.6M
EFX icon
24
Equifax
EFX
$21.4B
$62.6M 1.59%
645,017
-170,042
-21% -$16.6M
BIDU icon
25
Baidu
BIDU
$36.8B
$59.9M 1.52%
+300,799
New +$61.6M

Similar funds

PFM Health Sciences's Q2 2015 Portfolio in Review

As of Q2 2015, PFM Health Sciences held 121 positions worth $3.95B, up 8.9% from $3.63B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

PFM Health Sciences deployed $326M of net new capital in Q2 2015, opening 38 new positions and adding to 29 existing holdings. Its largest new stake was Aetna Inc: 779,930 shares worth $99.4M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 49% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Bausch Health, an estimated $100M trimmed.

  • PFM Health Sciences's largest Q2 2015 buy was Aetna Inc: 779,930 shares worth $99.4M.
  • PFM Health Sciences added most to HCA Healthcare in Q2 2015, an estimated $87.3M increase.
  • PFM Health Sciences's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $100M.
  • PFM Health Sciences fully exited McKesson in Q2 2015, selling an estimated $82.1M.
  • PFM Health Sciences's ten largest holdings make up 36% of its $3.95B portfolio in Q2 2015.
  • PFM Health Sciences opened 38 new positions and closed 34 in Q2 2015.
  • PFM Health Sciences's portfolio value rose 8.9% quarter-over-quarter to $3.95B.

Based on PFM Health Sciences's 13F filing for Q2 2015, filed 14 Aug 2015.